Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from HeraMED Ltd. ( (AU:HMD) ).
HeraMED Limited has issued 3,000,000 unquoted options under an employee incentive scheme, with various exercise prices and expiry dates, as notified in an Appendix 3G filing to the ASX. The new options, which will not be quoted on the exchange, form part of the company’s approach to staff and stakeholder remuneration, potentially aligning employee incentives more closely with long-term shareholder value and company performance.
More about HeraMED Ltd.
HeraMED Limited is a healthcare technology company that develops and commercialises digital health solutions, including connected medical devices and platforms, with a focus on remote patient monitoring and maternal health. The company is listed on the ASX under the code HMD and targets both clinical providers and consumer healthcare markets.
YTD Price Performance: 36.11%
Average Trading Volume: 1,595,153
Technical Sentiment Signal: Buy
Current Market Cap: A$56.59M
See more data about HMD stock on TipRanks’ Stock Analysis page.